Latest News & Features
Refine Search
Biotechnology
The US International Trade Commission will investigate whether drug manufacturers used trade secrets to develop a biosimilar of AbbVie’s Humira. 27 January 2022
Americas
AstraZeneca has urged the US Court of Appeals for the Federal Circuit to revisit a split panel decision that breathed new life into Mylan’s bid to produce a generic version of the asthma inhaler, Symbicort Turbohaler. 27 January 2022
article
The World Trade Organization’s TRIPS waiver was proposed back in October 2020 but stalled due to largely developing nations signing up to sponsor the waiver, as many developed nations opposed. 27 January 2022
Generics
A Virginia district court judge has recommended that buyers of cholesterol drug Zetia should not be granted class certification in pay-for-delay litigation against MSD and Glenmark Generics. 27 January 2022
Big Pharma
Mylan has been allowed to challenge Neurim's melatonin patent at trial following a ruling by the High Court of England and Wales that the generic drug maker did not contravene the legal principle of estoppel. 25 January 2022
Big Pharma
Effective support and guidance can achieve greater diversity in life sciences, say general counsel from Bristol Myers Squibb, AstraZeneca, The Chemours Company and Eli Lilly. 25 January 2022
Big Pharma
PeriRx has been hit with sanctions over its conduct after its breach of licensing suit failed in a patent licensing dispute against the University of California. 24 January 2022
Americas
The US Supreme Court has rejected a bid from generic drugmaker Mylan to overturn the NHK-Fintiv rule. 20 January 2022
Americas
Gilead Sciences has sued an array of pharmaceutical suppliers and distributors accusing them of forming a counterfeiting network and allegedly selling fake versions of its HIV medications. 20 January 2022
Biotechnology
While the effort to secure greater vaccine and treatment equality via an IP waiver is admirable, it could stifle innovation and create long-term problems, say Matthew Howell and Lauren Griffin of Alston & Bird. 20 January 2022